Dean Welsch

This inventor holds 22 USPTO granted patents and 8 published patent applications, plus 10 CIPO patents and 15 EPO patents, primarily in Cancer Treatment. Top assignees: Biomed Valley Discoveries, Inc., Vertex Pharmaceuticals, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dean Welsch. Retrieved from https://idiyas.com/inventor/dean-welsch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 10 (Patent Applications = 6)

EPO Patents = 15 (Patent Applications = 17)

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 31(Granted Patents)

Company Filing History:

22 out of 42

Biomed Valley Discoveries, Inc.

patents

5 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

3 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4. 1 out of 97

Albany Molecular Research, Inc.

patents

5. 1 out of 1,217

The United States of America as Represented by the Department of Health

patents

where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Non-ERK MAPK Pathway

CDK Inhibitors

Atypical BRAF Mutations

Anti-CD276 Antibodies

Crystalline Forms

PI3K/Akt Pathway

Type 2 MEK

RAF Inhibitors

TEM8 Antibodies

Tumor Detection

Cancer Compositions

Combination Therapies

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12599593 - METHODS AND COMPOSITIONS FOR TREATING NON-ERK MAPK PATHWAY INHIBITOR-RESISTANT CANCERS (2026-04-14),

2. 12582635 - COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS (2026-03-24),

3. 12187698 - Crystalline forms of CHClNO (2025-01-07),

4. 12076324 - Cancer treatments using combinations of CDK and ERK inhibitors (2024-09-03),

5. 11851498 - Anti-CD276 antibodies (B7H3) (2023-12-26),

6. 11679112 - Cancer treatments using combinations of CDK and ERK inhibitors (2023-06-20),

7. 11390600 - Crystalline forms of CHClNO (2022-07-19),

8. 11246859 - Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers (2022-02-15),

9. 11135225 - Cancer treatments using combinations of CDK and ERK inhibitors (2021-10-05),

10. 11013743 - Cancer treatments using combinations of CDK and ERK inhibitors (2021-05-25),

11. 11007184 - Cancer treatments using combinations of type 2 MEK and ERK inhibitors (2021-05-18),

12. 11007183 - Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors (2021-05-18),

13. 10881646 - Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers (2021-01-05),

14. 10738027 - Crystalline forms of CHClNO (2020-08-11),

15. 10668055 - Cancer treatment using combinations of ERK and RAF inhibitors (2020-06-02),

Title: Dean Welsch: Pioneering Inventor from Parkville

Introduction: Dean Welsch is a distinguished inventor hailing from Parkville, Missouri. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: Dean Welsch holds several patents in various technological domains, including advancements in renewable energy systems, smart home devices, and medical equipment. His recent patents focus on enhancing user experience and improving efficiency in everyday tasks.

Career Highlights: Throughout his illustrious career, Dean Welsch has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His inventions have garnered acclaim for their practicality and impact on society, earning him a reputation as a forward-thinker in the industry.

Collaborations: Dean Welsch has collaborated with leading tech companies and research institutions to bring his inventions to life. His partnerships have been instrumental in turning his visionary ideas into tangible products that have the potential to shape the future of technology.

Conclusion: Dean Welsch's relentless pursuit of innovation and his commitment to creating solutions that make a difference have solidified his position as a trailblazing inventor in Parkville and beyond. His contributions to the world of technology continue to inspire and drive progress in the ever-evolving landscape of invention.

Profile summary based on public USPTO records.